MADRID, (EUROPA PRESS) S’5 per cent of the donations of ri&bath;’re made in Espa&bath;to come from living donors, so that it begins to need to consider an increase of this type of donaci’n, as supondrían effective way to reduce the waiting lists, inform’ the Foundation’n Puigvert.
This is the reason why the foundation’n, with the sponsorship of the Organization’n National Transplantation (ONT), has organized the course you’rico-prápractical training’re in a Kidney Transplant from a Living Donor who has given beginning today. Despite the fact that Espa&bath;to have the program donaci’n cháver más important in the world, the waiting list of patients awaiting a transplant from ri&bath;’n sit&number;in the 4,000 people. That’s why, during the &number;last&years, have begun to accept the ’bodies of elderly donors, to heart’re unemployed or with a history of hipertensi’n, but has not been sufficient to cover all needs. Así, the foundation’n considers the need to work in the programs of living donors, as has been done in the united States and some países in europe. Además de la reducci’re waiting lists, living donor kidney transplant, s&number;n Puigvert, alsoén brings numerous advantages to the donor and the recipient, as it allows you to do the transplant early, i.e., before the patient has been subjected to a process of diálysis, avoiding to doing’n fístula arteriovenous or implantaci’n catéter of hemodiálysis or diálysis peritoneal. BEST RESULTS. Since it is a hand’re scheduled, it is performed at the time más appropriate for the giver and the receiver. Además, the results obtained are better by the half-life of ri&bath;’n from a living donor is más long that the donor’s cadáver. The time of ischemia –conservation’n en fríor the ri&bath;’n transplant– is lower, which impacts favorably in the transplant. In certain degrees of kinship, such as parents, children and siblings, allows an extremely good compatibility. The results of the transplantation of a ’body from a live donor, even though it is less compatible than that of a donor cháto see, can be better. Además, the risk of rejection; alsoén is lower. The study and readiness’n donaci’n, favors the detecci’re in the donor patologías treatable. The ri&bath;’n left to the donor grows later and hypertrophy. In this way, used to recover 80 percent of the function’initial n of the two ri&bathrooms;ones. Does not change the life expectancy of the donor and éste not take medication’n in the medium and/or long-term. The advantages of the donaci’re living donor are many. In spite of this, so that the patients can evaluate and make a decision’n, they are always informed of the risks, which are those that involves any intervention’n quir&number;rgica.